Skip to main content

and
  1. No Access

    Chapter

    Obstacles to Improved End-Results in Head and Neck Cancer

    The status of chemotherapy in the treatment of squamous cancers of the upper aerodigestive tract has been the subject of several recent comprehensive reviews (1,2,3). The drugs with measurable activity in thes...

    R. E. Wittes in Cancer Chemotherapy and Selective Drug Development (1984)

  2. No Access

    Article

    Chemotherapy of non-small cell lung cancer: Clinical trials at the Memorial Sloan-Kettering Cancer Center

    Bronchogenic carcinoma is one of the most difficult and pressing problems in cancer therapy. Overall survival of 799 primary cases at Memorial Sloan-Kettering Cancer Center was 7.8%, reflecting the advanced na.....

    R. J. Gralla, R. E. Wittes, E. S. Casper, D. P. Kelsen in World Journal of Surgery (1981)

  3. No Access

    Chapter and Conference Paper

    Combination Chemotherapy of Head and Neck Cancer in the United States

    In 1973 Bertino and co-workers [3] reviewed the chemotherapy of head and neck cancer. They concluded that “several agents are effective in the treatment of epidermoid cancers of the head and neck. The time is ...

    R. E. Wittes in New Drugs in Cancer Chemotherapy (1981)